Skip to main content

Initial Management of Youth with Type 1 Diabetes

  • Chapter
  • First Online:
Diabetes in Children and Adolescents

Part of the book series: Contemporary Endocrinology ((COE))

  • 876 Accesses

Abstract

The Yale T1D Treatment Program has utilized traditional, twice a day injections of insulin as initial treatment of youth with type 1 diabetes (T1D). Moreover, almost all of our newly diagnosed patients are admitted to the hospital when first diagnosed with T1D. While the limitations of twice a day insulin injections become more apparent over time, it is very effective during the initial treatment of T1D, since most youngsters go through a honeymoon period of increased endogenous insulin secretion during the first 6 months of diabetes. We refer to this approach as “The Bridge to Pump Treatment,” since most of our patients transition to pump therapy when metabolic control of diabetes because more difficult during the second half of the first year of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cengiz E, Tamborlane WV, Martin-Fredericksen M, Dziura J, Weinzimer SA. Early pharmacokinetic and pharmacodynamic effects of mixing lispro with glargine insulin: results of glucose clamp studies in youth with type 1 diabetes. Diabetes Care. 2010;33:1009–12.

    Article  CAS  Google Scholar 

  2. Cengiz E, Sherr JL, Sikes K, Urban A, Weinzimer SA. Tamborlane WV for the Yale Pediatric Type 1 Diabetes Treatment Team. A bridge to insulin pump therapy: BID regimen with NPH and detemir insulin during initial treatment of youth with type 1 diabetes. Endocr Pract. 2011;6:1–17.

    Google Scholar 

  3. Heise T, Nosek L, Ronn BB, et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes. 2004;53:1614–20.

    Article  CAS  Google Scholar 

  4. Danne T, Lupke K, Walte K, Von Schuetz W, Gall MA. Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes. Diabetes Care. 2003;26:3087–92.

    Article  CAS  Google Scholar 

  5. Diabetes Research in Children Network (DirecNet) and Type 1 Diabetes TrialNet Study Groups. Effectiveness of early intensive therapy on Beta cell preservation in type 1 diabetes. Diabetes care. Diabetes Care. 2013;36:4030–5.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kerry Stephenson .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Stephenson, K., Tamborlane, W.V. (2021). Initial Management of Youth with Type 1 Diabetes. In: Tamborlane, W.V. (eds) Diabetes in Children and Adolescents. Contemporary Endocrinology. Humana, Cham. https://doi.org/10.1007/978-3-030-64133-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-64133-7_4

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-64132-0

  • Online ISBN: 978-3-030-64133-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics